117,093 research outputs found

    Economics of organic farming (extension to OF0125)(0F0190)

    Get PDF
    This project OF0190 was an extension to OF0125 to cover completing the comparison data for 1997/98 and to extend the data collection by one further year (1998/99). The final reports for the two projects are therefore being submitted jointly. The OF0125 report covers the period 1995/96-1997/98, for which a detailed report was submitted to MAFF in July 1999, and a revised detailed report including a complete set of comparisons with conventional farms was submitted to MAFF, after revisions, in July 2000. That report has now been published at www.organic.aber.ac.uk/library/organic farm incomes.pdf. A detailed report for 1998/99 has been submitted to MAFF in March 2001, and will be published at the same internet site once accepted. The report presents results from research work carried out for the Ministry of Agriculture, Fisheries and Food (MAFF) on the financial performance of organic farms in 1998/99. The aim of the research was to assess the financial performance of organic farms differentiated by farm type, in order to inform MAFF policy-making with respect to organic farming, and to provide a basis for assessments by farmers, advisers and other interested parties of the farm-level implications of conversion to and continued organic farming. To provide an idea of the trends over time, where possible data for continuous samples of farms are presented for 1997/98 and 1998/99. The specific objectives were to extend the previous project (OF0125, covering 1995/96 to 1997/98) to collect and collate data on the financial performance of organic farms, differentiated by farm type . This was achieved through the collation of financial data collected under three different MAFF-funded research projects supplemented by data collected on other farm types. The samples of organic farms are small because of the limited number of organic holdings over 8 ESU (European Size Units) with identifiable holding numbers in 1996, when the previous study was started. As the sample is small there is limitation on how the results may be extrapolated to the wider population of organic farms, especially as the structure and objectives of those converting to organic production in the late 1990s may be different from those that converted in the 1970s and 1980s. Detailed financial input, output, income, liabilities and assets and some physical performance measures are presented for 1998/99. Where an identical sample of five farms is available, data are presented for 1997/98 and 1998/99 for the sample. The organic farm samples are so small that outliers (especially larger farms) have a large influence on the average. If the samples were larger, general trends would be more apparent and less influenced by individual farms; despite this, some explanation has been attempted of trends and changes in inputs, outputs and incomes. However, great care must be taken in extrapolating results. Of those farm types for which a continuous identical sample of five farms was available, Net Farm Incomes (NFI) increased for cropping (£281/ha) and dairy farms (£487/ha) in 1998/99 compared with 1997/98; in both cases outputs as well as inputs increased between years. Mixed farms showed an average reduction in outputs and increase in inputs, lowering the average NFI to £15/ha in 1998/99. The five lowland cattle and sheep farms improved a negative NFI of £161/ha in 1997/98 to a positive £7/ha in 1998/99 through an increase in livestock outputs with a similar level of inputs to that of 1997/98. Due to the high level of farmer and spouse labour on horticultural holdings, the average Management and Investment Income (MII) of the sample was negative, but the average NFI was £1,836/ha. On four holdings, 1998/99 average outputs were 92%, and inputs were 97% of the previous year, resulting in an average NFI in 1998/99 for that group of 75% of the 1997/98 result. The group of LFA farms, consisting of four cattle and sheep and one mixed farm, achieved an average NFI of £72/ha in 1998/99

    Regression with strongly correlated data

    Get PDF
    This paper discusses linear regression of strongly correlated data that arises, for example, in magnetohydrodynamic equilibrium reconstructions. We have proved that, generically, the covariance matrix of the estimated regression parameters for fixed sample size goes to zero as the correlations become unity. That is, in this limit the estimated parameters are known with perfect accuracy. Simple examples are shown to illustrate this effect and the nature of the exceptional cases in which the estimate covariance does not go to zero

    Formulation of design guidelines for automated robotic assembly in outerspace

    Get PDF
    The approach for arriving at design guidelines for assembly by robots in outerspace is illustrated. The use of robots in a zero gravity environment necessitates that extra factors over and above normal design guidelines be taken into account. Besides, many of the guidelines for assembly by robots on earth do not apply in space. However, considering the axioms for normal design and assembly as one set, guidelines for design and robotic assembly as another, and guidelines for design and assembly in space as the third set, unions and intersections of these sets can generate guidelines for two or more of these conditions taken together - say design and manual assembly in space. Therein lies the potential to develop expert systems in the future, which would use an exhaustive database and similar guidelines to arrive at those required by a superposition of these conditions

    Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

    Get PDF
    Objective We performed a review of studies of fluticasone propionate (FP)/salmeterol (SAL) (combination inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA)) in patients with COPD, which measured baseline (pretreatment) blood eosinophil levels, to test whether blood eosinophil levels ≥2% were associated with a greater reduction in exacerbation rates with ICS therapy. Methods Three studies of ≥1-year duration met the inclusion criteria. Moderate and severe exacerbation rates were analysed according to baseline blood eosinophil levels (<2% vs ≥2%). At baseline, 57–75% of patients had ≥2% blood eosinophils. Changes in FEV1 and St George’s Respiratory Questionnaire (SGRQ) scores were compared by eosinophil level. Results For patients with ≥2% eosinophils, FP/SAL was associated with significant reductions in exacerbation rates versus tiotropium (INSPIRE: n=719, rate ratio (RR)=0.75, 95% CI 0.60 to 0.92, p=0.006) and versus placebo (TRISTAN: n=1049, RR=0.63, 95% CI 0.50 to 0.79, p<0.001). No significant difference was seen in the <2% eosinophil subgroup in either study (INSPIRE: n=550, RR=1.18, 95% CI 0.92 to 1.51, p=0.186; TRISTAN: n=354, RR=0.99, 95% CI 0.67 to 1.47, p=0.957, respectively). In SCO30002 (n=373), no significant effects were observed (FP or FP/SAL vs placebo). No relationship was observed in any study between eosinophil subgroup and treatment effect on FEV1 and SGRQ. Discussion Baseline blood eosinophil levels may represent an informative marker for exacerbation reduction with ICS/LABA in patients with COPD and a history of moderate/severe exacerbations
    corecore